UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000010691
Receipt number R000009927
Scientific Title A Randomized PhaseI/ II study of HSP70mRNA transfected Dendritic Cells for the the Adjuvant immunotherapy of Hepatocellular carcinoma
Date of disclosure of the study information 2013/05/11
Last modified on 2020/05/18 11:21:18

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Randomized PhaseI/ II study of HSP70mRNA transfected Dendritic Cells for the the Adjuvant immunotherapy of Hepatocellular carcinoma

Acronym

H7DCAH study

Scientific Title

A Randomized PhaseI/ II study of HSP70mRNA transfected Dendritic Cells for the the Adjuvant immunotherapy of Hepatocellular carcinoma

Scientific Title:Acronym

H7DCAH study

Region

Japan


Condition

Condition

Hepatocellular carcinoma

Classification by specialty

Hepato-biliary-pancreatic surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Safety

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Phase I,II


Assessment

Primary outcomes

1 year Desease-Free Survival rate

Key secondary outcomes

Safety
Overall survival


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification

YES

Dynamic allocation

YES

Institution consideration


Blocking


Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Vaccine Other

Interventions/Control_1

Surgey and HSP70mRNA transfected Dendritic Cells for the the Adjuvant immunotherapy

Interventions/Control_2

surgery alone

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Diagnosed HCCs by dynamic CT or MRI and tumor markers
2. No therapy before 30 days for hepatectomy
3. R0 resection for Stage 2-4A (LIver cancer study group of Japan)

Key exclusion criteria

Without underlying diseases and allergy

Target sample size

45


Research contact person

Name of lead principal investigator

1st name Masaaki
Middle name
Last name Oka

Organization

Yamaguchi University Graduate School of Medicine

Division name

Digestive Surgey and Surgical Oncology

Zip code

755-8505

Address

1-1-1 Minami-Kogushi, Ube, Yamaguchi, 755-8505, Japan

TEL

+81-836-22-2264

Email

hazama@yamaguchi-u.ac.jp


Public contact

Name of contact person

1st name Shoichi
Middle name
Last name Hazama

Organization

Yamaguchi University Graduate School of Medicibe

Division name

Digestive Surgey and Surgical Oncology

Zip code

755-8505

Address

1-1-1 Minami-Kogushi, Ube, Yamaguchi, 755-8505, Japan

TEL

+81-836-22-2264

Homepage URL

http://ds.cc.yamaguchi-u.ac.jp/~surg2/

Email

hazama@yamaguchi-u.ac.jp


Sponsor or person

Institute

Digestive Surgey and Surgical Oncology,Yamaguchi University Graduate School of Medicibe

Institute

Department

Personal name



Funding Source

Organization

A Grant-in-Aid for Scientific Research of the Ministry of Education, Science, Sports and Culture of Japan (project No. 23591988).

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

Department of Clinical Laboratory, Yamaguchi University Hospital.

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Yamaguchi University

Address

1-1-1 Minami-Kogushi

Tel

81836222264

Email

hazama@yamaguchi-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

山口大学大学院消化器・腫瘍外科学


Other administrative information

Date of disclosure of the study information

2013 Year 05 Month 11 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2012 Year 06 Month 20 Day

Date of IRB

2012 Year 07 Month 13 Day

Anticipated trial start date

2012 Year 07 Month 13 Day

Last follow-up date

2019 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2013 Year 05 Month 10 Day

Last modified on

2020 Year 05 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009927